Fiem Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 4, 2025, 4:12 pm

Competitors of Fiem Industries Ltd

All Competitor Stocks of Fiem Industries Ltd

Quarterly Result

Last Updated: August 20, 2025, 10:55 am

Below is a detailed analysis of the quarterly data for Fiem Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 659.00 Cr.. The value appears strong and on an upward trend. It has increased from 639.00 Cr. (Mar 2025) to 659.00 Cr., marking an increase of 20.00 Cr..
• For Expenses, as of Jun 2025, the value is 569.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 554.00 Cr. (Mar 2025) to 569.00 Cr., marking an increase of 15.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 89.00 Cr.. The value appears strong and on an upward trend. It has increased from 85.00 Cr. (Mar 2025) to 89.00 Cr., marking an increase of 4.00 Cr..
• For OPM %, as of Jun 2025, the value is 14.00%. The value appears strong and on an upward trend. It has increased from 13.00% (Mar 2025) to 14.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2025) to 6.00 Cr., marking a decrease of 3.00 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2025, the value is 17.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 17.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 78.00 Cr.. The value appears strong and on an upward trend. It has increased from 77.00 Cr. (Mar 2025) to 78.00 Cr., marking an increase of 1.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Mar 2025) to 26.00%, marking an increase of 2.00%.
• For Net Profit, as of Jun 2025, the value is 58.00 Cr.. The value appears to be declining and may need further review. It has decreased from 59.00 Cr. (Mar 2025) to 58.00 Cr., marking a decrease of 1.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 21.85. The value appears to be declining and may need further review. It has decreased from 22.36 (Mar 2025) to 21.85, marking a decrease of 0.51.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:22 am

Growth

Last Updated: September 5, 2025, 3:55 am

Balance Sheet

Last Updated: June 16, 2025, 12:10 pm

Below is a detailed analysis of the balance sheet data for Fiem Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 26.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 26.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,012.00 Cr.. The value appears strong and on an upward trend. It has increased from 861.00 Cr. (Mar 2024) to 1,012.00 Cr., marking an increase of 151.00 Cr..
• For Borrowings, as of Mar 2025, the value is 22.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 23.00 Cr. (Mar 2024) to 22.00 Cr., marking a decrease of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 363.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 308.00 Cr. (Mar 2024) to 363.00 Cr., marking an increase of 55.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,424.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,218.00 Cr. (Mar 2024) to 1,424.00 Cr., marking an increase of 206.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 553.00 Cr.. The value appears strong and on an upward trend. It has increased from 496.00 Cr. (Mar 2024) to 553.00 Cr., marking an increase of 57.00 Cr..
• For CWIP, as of Mar 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2024) to 20.00 Cr., marking an increase of 15.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 850.00 Cr.. The value appears strong and on an upward trend. It has increased from 717.00 Cr. (Mar 2024) to 850.00 Cr., marking an increase of 133.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,424.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,218.00 Cr. (Mar 2024) to 1,424.00 Cr., marking an increase of 206.00 Cr..

Notably, the Reserves (1,012.00 Cr.) exceed the Borrowings (22.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Fiem Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 77.86. This value is within the healthy range. It has increased from 62.96 (Mar 24) to 77.86, marking an increase of 14.90.
• For Diluted EPS (Rs.), as of Mar 25, the value is 77.86. This value is within the healthy range. It has increased from 62.96 (Mar 24) to 77.86, marking an increase of 14.90.
• For Cash EPS (Rs.), as of Mar 25, the value is 102.29. This value is within the healthy range. It has increased from 85.29 (Mar 24) to 102.29, marking an increase of 17.00.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 394.45. It has increased from 336.98 (Mar 24) to 394.45, marking an increase of 57.47.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 394.45. It has increased from 336.98 (Mar 24) to 394.45, marking an increase of 57.47.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 920.46. It has increased from 770.82 (Mar 24) to 920.46, marking an increase of 149.64.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 128.54. This value is within the healthy range. It has increased from 108.15 (Mar 24) to 128.54, marking an increase of 20.39.
• For PBIT / Share (Rs.), as of Mar 25, the value is 104.12. This value is within the healthy range. It has increased from 85.87 (Mar 24) to 104.12, marking an increase of 18.25.
• For PBT / Share (Rs.), as of Mar 25, the value is 104.96. This value is within the healthy range. It has increased from 84.75 (Mar 24) to 104.96, marking an increase of 20.21.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 77.88. This value is within the healthy range. It has increased from 63.00 (Mar 24) to 77.88, marking an increase of 14.88.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 77.86. This value is within the healthy range. It has increased from 62.96 (Mar 24) to 77.86, marking an increase of 14.90.
• For PBDIT Margin (%), as of Mar 25, the value is 13.96. This value is within the healthy range. It has decreased from 14.03 (Mar 24) to 13.96, marking a decrease of 0.07.
• For PBIT Margin (%), as of Mar 25, the value is 11.31. This value is within the healthy range. It has increased from 11.13 (Mar 24) to 11.31, marking an increase of 0.18.
• For PBT Margin (%), as of Mar 25, the value is 11.40. This value is within the healthy range. It has increased from 10.99 (Mar 24) to 11.40, marking an increase of 0.41.
• For Net Profit Margin (%), as of Mar 25, the value is 8.46. This value is within the healthy range. It has increased from 8.17 (Mar 24) to 8.46, marking an increase of 0.29.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.45. This value is within the healthy range. It has increased from 8.16 (Mar 24) to 8.45, marking an increase of 0.29.
• For Return on Networth / Equity (%), as of Mar 25, the value is 19.73. This value is within the healthy range. It has increased from 18.68 (Mar 24) to 19.73, marking an increase of 1.05.
• For Return on Capital Employeed (%), as of Mar 25, the value is 25.15. This value is within the healthy range. It has increased from 24.11 (Mar 24) to 25.15, marking an increase of 1.04.
• For Return On Assets (%), as of Mar 25, the value is 14.39. This value is within the healthy range. It has increased from 13.59 (Mar 24) to 14.39, marking an increase of 0.80.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.83. It has increased from 1.79 (Mar 24) to 1.83, marking an increase of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 2.47. This value is within the healthy range. It has increased from 2.46 (Mar 24) to 2.47, marking an increase of 0.01.
• For Quick Ratio (X), as of Mar 25, the value is 1.77. This value is within the healthy range. It has increased from 1.74 (Mar 24) to 1.77, marking an increase of 0.03.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 10.99. This value exceeds the healthy maximum of 8. It has increased from 6.54 (Mar 24) to 10.99, marking an increase of 4.45.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 25.68. This value is within the healthy range. It has increased from 23.82 (Mar 24) to 25.68, marking an increase of 1.86.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 19.55. This value is below the healthy minimum of 20. It has increased from 17.59 (Mar 24) to 19.55, marking an increase of 1.96.
• For Earning Retention Ratio (%), as of Mar 25, the value is 74.32. This value exceeds the healthy maximum of 70. It has decreased from 76.18 (Mar 24) to 74.32, marking a decrease of 1.86.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 80.45. This value exceeds the healthy maximum of 70. It has decreased from 82.41 (Mar 24) to 80.45, marking a decrease of 1.96.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 219.21. This value is within the healthy range. It has increased from 96.88 (Mar 24) to 219.21, marking an increase of 122.33.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 131.38. This value is within the healthy range. It has increased from 57.43 (Mar 24) to 131.38, marking an increase of 73.95.
• For Enterprise Value (Cr.), as of Mar 25, the value is 3,403.03. It has increased from 2,795.12 (Mar 24) to 3,403.03, marking an increase of 607.91.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.40. This value is within the healthy range. It has increased from 1.38 (Mar 24) to 1.40, marking an increase of 0.02.
• For EV / EBITDA (X), as of Mar 25, the value is 10.06. This value is within the healthy range. It has increased from 9.82 (Mar 24) to 10.06, marking an increase of 0.24.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.53. This value is within the healthy range. It has increased from 1.48 (Mar 24) to 1.53, marking an increase of 0.05.
• For Retention Ratios (%), as of Mar 25, the value is 74.31. This value exceeds the healthy maximum of 70. It has decreased from 76.17 (Mar 24) to 74.31, marking a decrease of 1.86.
• For Price / BV (X), as of Mar 25, the value is 3.57. This value exceeds the healthy maximum of 3. It has increased from 3.38 (Mar 24) to 3.57, marking an increase of 0.19.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.53. This value is within the healthy range. It has increased from 1.48 (Mar 24) to 1.53, marking an increase of 0.05.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness